These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 22423577

  • 1. Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation.
    Robles-Piedras AL, Romano-Moreno S, Fuentes-Noriega I, Mancilla-Urrea E, González-López EH, Domínguez-Ramírez A.
    Proc West Pharmacol Soc; 2011; 54():30-2. PubMed ID: 22423577
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE, Willis C, Taylor PJ, Tett SE.
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [Abstract] [Full Text] [Related]

  • 3. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR, Vanrenterghem Y.
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K, Fritsche L, Mai I, Bauer S, Smettan S, Waiser J, Hofmann T, Hauser I, Reinke P, Neumayer HH.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [Abstract] [Full Text] [Related]

  • 6. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
    Minematsu T, Sugiyama E, Kusama M, Hori S, Yamada Y, Ohtani H, Sawada Y, Sato H, Takayama T, Sugawara Y, Makuuchi M, Iga T.
    Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.
    Lemahieu WP, Maes BD, Vanrenterghem Y.
    Transplant Proc; 2005 Jun; 37(5):2051-3. PubMed ID: 15964336
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circadian and time-dependent variability in tacrolimus pharmacokinetics.
    Park SI, Felipe CR, Pinheiro-Machado PG, Garcia R, Tedesco-Silva H, Medina-Pestana JO.
    Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A.
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [Abstract] [Full Text] [Related]

  • 18. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ.
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [Abstract] [Full Text] [Related]

  • 19. Conversion to tacrolimus extended-release formulation: short-term clinical results.
    Gallego-Valcarce E, Ortega-Cerrato A, Llamas-Fuentes F, Martinez-Fernandez G, Perez-Martinez J, Gomez-Roldan C.
    Transplant Proc; 2009 Mar; 41(6):2326-7. PubMed ID: 19715909
    [Abstract] [Full Text] [Related]

  • 20. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
    Min DI, Chen HY, Lee MK, Ashton K, Martin MF.
    Pharmacotherapy; 1997 Mar; 17(3):457-63. PubMed ID: 9165550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.